Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-25 | H. Ward Wolff currently serves as a member of the boards of directors of Portola Pharmaceuticals Inc. and Calithera Biosciences, Inc. ... On February 2, 2018, the Board appointed H. Ward Wolff as a director and as the chair of the Audit Committee. ... Mr. Wolff does not hold any shares of our common stock exercisable within 60 days of March 1, 2018. |
| 2019-04-12 | H. Ward Wolff currently serves as a member of the boards of directors of Portola Pharmaceuticals Inc. ... Mr. Wolff served as Executive Vice President and Chief Financial Officer of Sangamo Therapeutics, Inc. ... Committees: Audit Committee (Chairman). ... Director Compensation Table: H. Ward Wolff Fees Earned or Paid in Cash $60,000, Option Awards $216,080, Total $276,080. |
| 2020-04-28 | H. Ward Wolff currently serves as a member of the boards of directors of Portola Pharmaceuticals Inc. The Director Compensation Table shows total compensation of $103,608 for 2019. He serves as Chairman of the Audit Committee. |
Data sourced from SEC filings. Last updated: 2026-03-09